Study Forecasts 7.0% CAGR, with the CDMO Market Expanding from $136.6 Billion in 2024 to $191.6 Billion by 2029, Fueled by Increased Demand for Outsourced Drug Development and Manufacturing.Boston, ...
Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...
Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...
U.S. President Donald Trump plans to introduce tariffs on imported computer chips, pharmaceuticals, and steel to encourage ...
The Federal Circuit left in place a pair of orders blocking two competitors of Regeneron Pharmaceuticals Inc. from marketing ...
The Register on MSN13h
Trump eyes up to 100% tariffs on foreign semiconductors, TSMC in crosshairsAmericans could soon see the price of electronics skyrocket in response to a 25-100 percent import tariff on computer chips ...
K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...
The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...
Will proposed tariffs up to 100% on semiconductors made in Taiwan incentivize investment in U.S. capacity or dramatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback